Post-earnings recap
Reported
Wed, Oct 30, 2024
EPS actual
$4.08
EPS est.
$3.77
EPS surprise
+8.25%
1-day move
-1.25%
Biogen's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 1.25% in response, likely due to the lack of revenue details and future guidance. Investors may be cautious as they await more information on the company's performance and strategy moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.08 | N/A | +8.25% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to pipeline development. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value through our pipeline.
Est. EPS
—
Est. Rev
—
Impl. Move
—